Candida auris (C. auris) poses a serious global health threat due to its drug resistance, ability to persist on surfaces, and high...

Join us Wednesday, September 25, at the Westin Copley Place, where our CEO, Ted Eveleth, will showcase our groundbreaking work. The RESI...

We are thrilled to announce that AvantGuard has been named a Semi-Finalist in the 2024 Pepperdine Most Fundable Companies competition!...

Join us in celebrating Dr. Carine Nkemngong's latest paper, co-authored with Peter Teska from Diversey , on the critical role of...

We’re thrilled to announce that Ted Eveleth and Michael Newell recently joined Nishith (Nish) Acharya on Equal Innovation’s podcast, The...

AvantGuard's CEO attended three key medical conferences in May, showcasing commitment to advancing wound care and medical technologies.

AvantGuard is thrilled to share we have been chosen as one of the prestigious Hello Tomorrow Deep Tech Pioneers ! This recognition is a...

AvantGuard, a leading pioneer in antimicrobial solutions, was thrilled to have our CEO, Ted Eveleth, participate in the New York State...

We are thrilled to announce that AvantGuard has been recognized as a key player in the global Surface Disinfectants market by IMIR Market...

In the bustling landscape of innovation, AvantGuard emerged as a beacon of groundbreaking technology at this year's TechCrunch Disrupt...

AvantGuard's journey at TechCrunch Disrupt 2023 was nothing short of amazing! Ted Eveleth, AvantGuard's CEO, showcased the groundbreaking...

Nosocomial infections, commonly know as healthcare associated infections (HAIs) strike 1 in 31 hospital patients daily, but we can fight...

We are excited to announce that AvantGuard has been handpicked to exhibit at TechCrunch Disrupt 2023, earning a coveted spot in the...